Newsroom
Latest News from UNC Lineberger
-
UNC honors Bálint, Barnett and White with Postdoctoral Awards for Research ExcellenceThree postdoctoral scholars from the labs of UNC Lineberger members are being honored with PARE Awards, which are given in recognition of the research promise demonstrated by each individual.
-
New treatments offer promise to people with acute myeloid leukemiaJoshua Zeidner, MD, a hematologist/oncologist specializing in the management of acute leukemia, explains some of the advances in the treatment of acute myeloid leukemia (AML).
-
Scientific retreat highlights the depth and breadth of cancer center researchThe annual scientific retreat featured scientific presentations, a state of the cancer center overview from UNC Lineberger Director Shelley Earp, MD, and a talk on the cancer center’s future direction … Read more
-
Rashid awarded grant to develop AI tool that recommends optimal clinical trials to pancreatic cancer patientsNaim Rashid, PhD, has received a Department of Defense Pancreatic Cancer Research Program pilot award to build an AI tool that generates personalized clinical trial recommendations for patients with PDAC.
-
Pluta honored with School of Medicine Dean’s Performance AwardLinda Pluta, manager of the UNC Lineberger Vironomics Core facility, was presented with the Dean’s Performance Award. She and seven other award winners were recognized at the 2024 School of … Read more
-
Six surprising facts about breast cancerWhile breast cancer is one of the most common cancers in women, there are still some things you may not know about it. Here are six lesser-known facts about breast … Read more
-
A few minutes with Kate Ashcraft, PhDKate Ashcraft, PhD, is a research science liaison in the UNC Lineberger Clinical Trials Office who brings her passion for scientific exploration into every facet of her role.
-
Radiation vs. chemo: how to decide what’s bestTrevor Hackman, MD, explains some of the common options for cancer treatment and what your doctor considers when making a recommendation.
-
Rushing receives $3.9 million NCI grant to create the Human Cancer Metabolome AtlasBlake Rushing, PhD, will support the development of the Human Cancer Metabolome Atlas. The project aims to map the complex metabolic processes that drive cancer’s progression and resistance to treatment.
-
New compound shows promise in targeting cancer-linked proteinLindsey James, PhD, and colleagues have developed a promising new compound that selectively and effectively breaks down a protein linked to various cancers, including multiple myeloma and prostate cancer.